Arcus Biosciences, Inc. (RCUS) Social Stream
ARCUS BIOSCIENCES INC (RCUS) Price Targets From Analysts
Use the tables below to see what analysts covering ARCUS BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 8 | $70 | $50 | $59.833 | $35.17 | 70.13% |
| 2021-11-17 | 8 | $70 | $48 | $58.142 | $35.17 | 65.32% |
| 2021-11-18 | 8 | $100 | $48 | $62.714 | $35.17 | 78.32% |
| 2021-11-22 | 9 | $100 | $48 | $64.857 | $35.17 | 84.41% |
| 2022-02-24 | 7 | $100.001 | $53 | $67 | $35.17 | 90.5% |
| 2022-04-12 | 7 | $100.001 | $53 | $68 | $35.17 | 93.35% |
| 2022-05-10 | 7 | $77 | $53 | $63.143 | $35.17 | 79.54% |
| 2022-05-13 | 7 | $77 | $42 | $59.571 | $35.17 | 69.38% |
| 2022-07-08 | 7 | $66 | $42 | $55.714 | $35.17 | 58.41% |
| 2022-08-04 | 7 | $60 | $36 | $50.428 | $35.17 | 43.38% |
| 2022-08-18 | 7 | $60 | $36 | $48.571 | $35.17 | 38.1% |
| 2022-08-31 | 8 | $60 | $36 | $48.875 | $35.17 | 38.97% |
| 2022-10-11 | 9 | $60 | $36 | $47.875 | $35.17 | 36.12% |
| 2022-10-14 | 8 | $60 | $36 | $45.285 | $35.17 | 28.76% |
| 2022-11-03 | 7 | $60 | $36 | $45.125 | $35.17 | 28.31% |
| 2022-11-18 | 7 | $51 | $33 | $41.75 | $35.17 | 18.71% |
| 2022-11-23 | 8 | $51 | $33 | $41.375 | $35.17 | 17.64% |
The Trend in the Analyst Price Target
Over the past 138 days, RCUS's average price target has gone down $14.34.
Over the past 45 weeks, RCUS's average upside potential has been 103.94%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-01 | 7 | 100.001 | 53 | 68.000 | 31.99 | 112.57% |
| 2022-04-12 | 7 | 100.001 | 53 | 68.000 | 30.75 | 121.14% |
| 2022-10-14 | 8 | 60.000 | 36 | 45.285 | 26.64 | 69.99% |
| 2022-11-03 | 8 | 60.000 | 36 | 45.125 | 24.37 | 85.17% |
| 2022-11-18 | 8 | 51.000 | 33 | 41.750 | 27.31 | 52.87% |
RCUS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.31 | 6 | 1 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 43 weeks, RCUS's average broker recommendation rating worsened by 0.38.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RCUS as an investment opportunity.
- In terms of how ARCUS BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 716.62% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ARCUS BIOSCIENCES INC's average analyst price target is higher than 1960.1% of them.
- RCUS has a lower variance in analysts' estimates than -962.02% of Pharmaceutical Products stocks.
- In terms of how ARCUS BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 1690.75% of that group.
In the Pharmaceutical Products industry, HCM, MYOV, and ORGO are the three stocks most similar to ARCUS BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for RCUS? Use POWR Ratings for clearer insight into price direction.